117 related articles for article (PubMed ID: 29781860)
21. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
[TBL] [Abstract][Full Text] [Related]
22. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
[TBL] [Abstract][Full Text] [Related]
23. "Squamoid eccrine ductal carcinoma": an unusual low-grade case with follicular differentiation. Are these tumors squamoid variants of microcystic adnexal carcinoma?
Kavand S; Cassarino DS
Am J Dermatopathol; 2009 Dec; 31(8):849-52. PubMed ID: 19786851
[TBL] [Abstract][Full Text] [Related]
24. p63 Immunohistochemistry is a useful adjunct in distinguishing sclerosing cutaneous tumors.
Vidal CI; Goldberg M; Burstein DE; Emanuel HJ; Emanuel PO
Am J Dermatopathol; 2010 May; 32(3):257-261. PubMed ID: 20098297
[TBL] [Abstract][Full Text] [Related]
25. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases.
Fujiwara M; Taube J; Sharma M; McCalmont TH; Kim J
J Cutan Pathol; 2010 Sep; 37(9):938-43. PubMed ID: 20492080
[TBL] [Abstract][Full Text] [Related]
26. Role of immunohistochemistry in diagnosing tumors of cutaneous appendages.
Hoang MP
Am J Dermatopathol; 2011 Dec; 33(8):765-71; quiz 772-4. PubMed ID: 22112636
[TBL] [Abstract][Full Text] [Related]
27. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma.
Alomari AK; Glusac EJ; McNiff JM
J Cutan Pathol; 2014 Nov; 41(11):839-45. PubMed ID: 25263848
[TBL] [Abstract][Full Text] [Related]
28. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases.
Lee JJ; Mochel MC; Piris A; Boussahmain C; Mahalingam M; Hoang MP
Hum Pathol; 2014 May; 45(5):1078-83. PubMed ID: 24746214
[TBL] [Abstract][Full Text] [Related]
29. Metaplastic breast carcinoma histologically mimicking cutaneous spindle cell squamous cell carcinoma.
DeRienzo DP; Barr RJ
Am J Dermatopathol; 2005 Jun; 27(3):250-4. PubMed ID: 15900133
[TBL] [Abstract][Full Text] [Related]
30. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
Pu RT; Pang Y; Michael CW
Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
[TBL] [Abstract][Full Text] [Related]
31. Update on Immunohistochemical Analysis in Breast Lesions.
Peng Y; Butt YM; Chen B; Zhang X; Tang P
Arch Pathol Lab Med; 2017 Aug; 141(8):1033-1051. PubMed ID: 28574279
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical techniques to compare primary vs. metastatic mucinous carcinoma of the skin.
Levy G; Finkelstein A; McNiff JM
J Cutan Pathol; 2010 Apr; 37(4):411-5. PubMed ID: 19788442
[TBL] [Abstract][Full Text] [Related]
33. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
36. CD117 (KIT) is a useful immunohistochemical marker for differentiating porocarcinoma from squamous cell carcinoma.
Goto K; Takai T; Fukumoto T; Anan T; Kimura T; Ansai S; Oshitani Y; Murata Y; Sakuma T; Hirose T
J Cutan Pathol; 2016 Mar; 43(3):219-26. PubMed ID: 26449497
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
[TBL] [Abstract][Full Text] [Related]
38. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin.
Ivan D; Nash JW; Prieto VG; Calonje E; Lyle S; Diwan AH; Lazar AJ
J Cutan Pathol; 2007 Jun; 34(6):474-80. PubMed ID: 17518775
[TBL] [Abstract][Full Text] [Related]
39. Androgen receptors: a marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site.
Bayer-Garner IB; Smoller B
Mod Pathol; 2000 Feb; 13(2):119-22. PubMed ID: 10697267
[TBL] [Abstract][Full Text] [Related]
40. Squamous cell carcinoma in serous effusions: Avoiding pitfalls in this rare encounter.
LePhong C; Hubbard EW; Van Meter S; Nodit L
Diagn Cytopathol; 2017 Dec; 45(12):1095-1099. PubMed ID: 29024544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
